Ron Bentsur - 26 May 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
26 May 2022
Net transactions value
+$15,820
Form type
4
Filing time
31 May 2022, 08:31:27 UTC
Previous filing
23 May 2022
Next filing
27 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $7,950 +500 +0.02% $15.90 2,963,114 26 May 2022 Direct F1
transaction NVCT Common Stock Purchase $7,870 +500 +0.02% $15.74 2,963,614 27 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.